Siler Panowski

Siler Panowski is an experienced scientist specializing in cancer immunotherapy and novel therapeutic development. Having held key positions at Pfizer Rinat as a Principal Scientist and Senior Scientist, Siler led teams in CAR T cell and bispecific target discovery, managing multiple therapeutic programs from early preclinical stages to IND-enabling studies. At Genentech, Siler worked on large molecule cancer therapeutics, focusing on Antibody-Drug Conjugates and bispecific antibodies. Recent roles at Allogene Therapeutics included Executive Director of Biology for Solid Tumors, where responsibilities encompassed directing research and overseeing clinical candidate development. Currently, Siler serves as Vice President of Candidate Development at Dispatch Bio, leading the advancement of novel cell therapeutics for solid tumors. Siler holds a PhD in Molecular and Cell Biology from the University of California, San Diego, and a BA in Molecular and Cell Biology from the University of California, Berkeley.